journal article·2015-12

NF‐κB decoy oligodeoxynucleotide inhibits wear particle‐induced inflammation in a murine calvarial model

Taishi Sato, Jukka Pajarinen, Tzu‐hua Lin, Yasunobu Tamaki, Florence Loi, Kensuke Egashira, Zhenyu Yao, Stuart B. Goodman

Publisher page

Abstract

Abstract Wear particles induce periprosthetic inflammation and osteolysis through activation of nuclear factor kappa B (NF‐κB), which up‐regulates the downstream target gene expression for proinflammatory cytokines in macrophages. It was hypothesized that direct suppression of NF‐κB activity in the early phases of this disorder could be a therapeutic strategy for preventing the inflammatory response to wear particles, potentially mitigating osteolysis. NF‐κB activity can be suppressed via competitive binding with double stranded NF‐κB decoy oligodeoxynucleotides (ODNs) that blocks this transcription factor from binding to the promoter regions of targeted genes. In this murine calvarial study, clinically relevant polyethylene particles (PEs) with/without ODN were subcutaneously injected over the calvarial bone. In the presence of PE particles, macrophages migrated to the inflammatory site and induced tumor necrosis factor alpha (TNF‐α) and receptor activator of nuclear factor kappa B ligand (RANKL) expression, resulting in an increase in the number of osteoclasts. Local injections of ODN mitigated the expression of TNF‐α, RANKL, and induced the expression of two anti‐inflammatory, antiresorptive cytokines: interleukin‐1 receptor antagonist and osteoprotegerin. Local intervention with NF‐κB decoy ODN in early cases of particle‐induced inflammation in which the prosthesis is still salvageable may potentially preserve periprosthetic bone stock. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 3872–3878, 2015.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Bone Metabolism and Diseases · Bone and Joint Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedic Surgery Stanford University Stanford California

Department of Orthopaedic Surgery Yamagata University School of Medicine Yamagata Japan

Department of Cardiovascular Research Development and Translational Medicine Kyushu University Fukuoka Japan

Department of Bioengineering Stanford University Stanford California

Funding

NIH · Ellenburg Chair in Surgery in Stanford University

References (23)

Show source-provided references
1. 10.1016/j.biomaterials.2007.06.03510.1016/j.biomaterials.2007.06.035 ↗
2. 10.1016/j.actbio.2013.09.03410.1016/j.actbio.2013.09.034 ↗
3. 10.1056/NEJM19880324318120510.1056/NEJM198803243181205 ↗
4. 10.1172/JCI20052339410.1172/JCI200523394 ↗
5. 10.1007/s11095-011-0366-010.1007/s11095-011-0366-0 ↗
6. 10.1007/s00198-013-2313-x10.1007/s00198-013-2313-x ↗
7. 10.1016/S0736-0266(03)00156-610.1016/S0736-0266(03)00156-6 ↗
8. 10.2174/15680261280353139710.2174/156802612803531397 ↗
9. 10.1016/j.actbio.2014.04.03410.1016/j.actbio.2014.04.034 ↗
10. 10.1089/ars.2008.235510.1089/ars.2008.2355 ↗
11. 10.4049/jimmunol.173.9.576610.4049/jimmunol.173.9.5766 ↗
12. 10.1016/j.jss.2013.10.02710.1016/j.jss.2013.10.027 ↗
13. 10.1016/j.yexcr.2014.07.00510.1016/j.yexcr.2014.07.005 ↗
14. 10.1016/j.jss.2011.11.00410.1016/j.jss.2011.11.004 ↗
15. 10.1007/s00264-013-1887-410.1007/s00264-013-1887-4 ↗
16. 10.1002/jbmr.14110.1002/jbmr.141 ↗
17. 10.1074/jbc.M113.47126810.1074/jbc.M113.471268 ↗
18. 10.1002/jor.110018032110.1002/jor.1100180321 ↗
19. 10.1007/978-1-4939-0669-7_1010.1007/978-1-4939-0669-7_10 ↗
20. 10.1002/jor.2155510.1002/jor.21555 ↗
21. 10.1001/jama.292.4.49010.1001/jama.292.4.490 ↗
22. 10.1016/S0736-0266(01)00083-310.1016/S0736-0266(01)00083-3 ↗
23. 10.1089/ten.tea.2014.014410.1089/ten.tea.2014.0144 ↗